Hypnotherapy in Treating Chronic Pain in Cancer Survivors
CompletedNot applicableNCT02637297
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This randomized pilot clinical trial studies hypnotherapy in treating chronic pain in cancer survivors. Hypnotherapy is a state of concentration and focused attention which can provide more control over the experience of acute and chronic pain and its impact and may provide comfort, maximize function, and improve quality of life in cancer survivors.
Study details
- Official title
- Hypnosis for Pain Management With Cancer Survivors
- Conditions
- Anxiety
- Cancer Survivor
- Chronic Pain
- Depression
- Sleep Disorder
- Interventions
- Procedure: Hypnotherapy
- Other: Questionnaire Administration
- Sponsor
- Fred Hutchinson Cancer Center
- Collaborators
- National Cancer Institute (NCI); National Institute of Nursing Research (NINR); American Nurses Foundation
- Start date
- 2016-01-08
- Primary completion
- 2017-02-09
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Self-report of moderate or higher pain on average during the last week (\> 3 on a 0-10 pain intensity numeric scale) * Completed active cancer treatment other than maintenance therapy \>= 3 months ago * Functional fluency in English * Mentally and physically able to participate and complete surveys over the phone Exclusion Criteria: * Chronic pain is not cancer-related
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02637297